<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04913038</url>
  </required_header>
  <id_info>
    <org_study_id>2020_92</org_study_id>
    <secondary_id>2021-A00487-34</secondary_id>
    <nct_id>NCT04913038</nct_id>
  </id_info>
  <brief_title>Validation of the ANI in Perpubescent Patients in Pediatric Intensive Care Unit.</brief_title>
  <acronym>ANI-EP</acronym>
  <official_title>Assessment of the Validity of the ANI in Children Over 2 Years of Age and Prepubescent Ventilated and Sedated in Pediatric Intensive Care.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ANI monitor is a medical device allowing to measure the response of the autonomic nervous&#xD;
      system to a painful stimulus.&#xD;
&#xD;
      In the pediatric population under general anesthesia, the ANI score can detect failure of&#xD;
      locoregional anesthesia; ANI decreases after painful stimulation during surgery, more&#xD;
      markedly with smaller doses of Remifentanil.&#xD;
&#xD;
      To date, measurement of ANI in sedated children in pediatric intensive care has not been&#xD;
      performed or validated as a method of assessing pain and discomfort.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 29, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia Nociception Index (ANI) minimum</measure>
    <time_frame>at 10 minutes before the painful care</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ANI minimum</measure>
    <time_frame>at 30 minutes (average lenght of painful care)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ANI minimum</measure>
    <time_frame>at 10 minutes after the painful care</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Variation of ANI minimum between before and after a painful care</measure>
    <time_frame>From 10 minutes before the care to 10 minutes after the care</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the correlation between ANI minimum and the COMFORT B behavioral scale.</measure>
    <time_frame>From 10 minutes before the care to 10 minutes after the care</time_frame>
    <description>The COMFORT BEHAVIOURAL (COMFORT-B) SCALE consists of six items: alertness, calmness, respiratory response, body movements, facial tension and muscle tone. Each item goes from 1 to 5, assessing the different intensities. The sum of the six ratings leads to a final score ranging from a minimum of 6 to a maximum of 30. A patient is considered to be under-sedated in case of COMFORT-B scores of 23 or higher, over-sedated in case of COMFORT-B scores of 10 or lower.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the ability of ANI minimum to distingush painful from non painful patient</measure>
    <time_frame>From 10 minutes before the care to 10 minutes after the care</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the ROC curve of ANI min calculated over all measurements</measure>
    <time_frame>From 10 minutes before the care to 10 minutes after the care</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain</condition>
  <condition>Pediatric ALL</condition>
  <arm_group>
    <arm_group_label>case group</arm_group_label>
    <description>children over 2 years of age and prepubescent ventilated and sedated in pediatric intensive care.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        children over 2 years of age and prepubescent ventilated and sedated in pediatric intensive&#xD;
        care&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Prebubescent chilren (up to 2 years old) Admited in PICU Sedated, ventilated&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non sinusal rythm&#xD;
&#xD;
          -  Atropine&#xD;
&#xD;
          -  Pace-macker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morgan RECHER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Morgan RECHER, MD</last_name>
    <phone>0320445962</phone>
    <phone_ext>+33</phone_ext>
    <email>morgan.recher@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hop Jeanne de Flandre Chu Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>0320445962</phone>
      <email>DRS@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Morgan RECHER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 17, 2021</study_first_submitted>
  <study_first_submitted_qc>June 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intensive Care Units,</keyword>
  <keyword>Pain Measurement</keyword>
  <keyword>ANI, Analgesia Nociception Index</keyword>
  <keyword>Pediatric,</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

